As resveratrol treatment counteracted the effect of evodiamine in inducing α-tubulin acetylation and augmenting NLRP3 inflammasome activation in vitro, we finally explored whether resveratrol could reverse evodiamine-mediated augmentation of innate immune responses against bacterial infection in vivo. Here, NLRP3 is linked to bacterial infectious disease.